NewTimeSpace News: On 24 August 2026, CF PHARMTECH (02652.HK) announced that its self-developed long-acting inhaled dry powder drug candidate ICF001 has obtained implied approval from the NMPA to conduct clinical trials for IPF and PPF, expanding its indications to four following the earlier approvals for PAH and PH-ILD; the Company plans to conduct Phase I clinical trials in China and explore global multi-center development and cooperation opportunities.
NewTimeSpace News: On 24 August 2026, BAO PHARMA-B (02659.HK) announced that the FDA has approved the IND application for its self-developed KJ015 injection, an anti-HER2 bispecific antibody subcutaneous formulation, permitting clinical trials in the United States; KJ015 previously received IND approval from the National Medical Products Administration in December 2024, with Phase I clinical trials in China commenced in June 2025 and expected to be completed in the second half of 2026.
On August 24, 2026, the technology theme pulled back sharply, and AI concept stocks weakened across the board today. The Hang Seng Index fell 1.89%, the Hang Seng TECH Index dropped 3.61%, and the Hang Seng China Enterprises Index fell 1.89%. The Hang Seng Index's full-day total market turnover was HKD 291.2 billion, with southbound funds recording a net inflow of HKD 11.567 billion.The smart-driving segment was mixed: WERIDE-W (00800.HK) rose 1.54% against the trend, ROBOSENSE (02498.HK) fell 14.52%, and HORIZONROBOT-W, BLACK SESAME, and PONY-W followed lower.
NewTimeSpace News: On 24 August 2026, BAIYUNSHAN PH (00874.HK) announced that the Norepinephrine Bitartrate Injection (1ml:2mg) of its wholly-owned subsidiary Mingxing Pharmaceutical has passed the generic drug quality and efficacy consistency evaluation, with domestic sales of the drug amounting to RMB 768.58 million in 2025 and R&D investment of approximately RMB 1.2557 million (unaudited).
NewTimeSpace News: On August 24, 2026, XPENG-W (09868.HK) weakened in the afternoon. As of 14:04, the stock traded at HK$47.18, down 1.91%.
NewTimeSpace (newtimespace.com) News, August 24, 2026—the chip theme pulled back sharply, and HUA HONG GRACE (01347.HK) weakened amid volatility. As of 13:23, the company's quote stood at HKD 108.500, down 5.49%.
NewTimeSpace (newtimespace.com) News, August 24, 2026—the robot theme lost momentum, yet MIDEA GROUP (00300.HK) swung higher. As of 13:16, the company's quote stood at HKD 98.000, up 1.14%.
NewTimeSpace News: AIM Vaccine announced on August 24 that the marketing authorization application for its self-developed high-potency human diploid rabies vaccine adopting an optimized production process has been submitted to the National Medical Products Administration.
On August 21, 2026, the three major Hong Kong stock indices continued to strengthen — the Hang Seng Index rose 1.21%, the Hang Seng TECH Index gained 1.40%, and the Hang Seng China Enterprises Index advanced 1.01%. AI concept themes strengthened collectively on the day, while leading tech and internet stocks were mixed.In the large-model segment, the "twin leaders" surged — MINIMAX-W (00100.HK) rose 11.86%, Z.AI (02513.HK) gained 10.36%, with TENCENT, KUAISHOU-W and BIDU-SW following the gains. ALIBABA-W (09988.HK) fell 2.54% post-earnings, and MEITUAN-W dropped 0.99%.
NewTimeSpace News: On 21 August 2026, SHANDONG XINHUA (00719.HK) announced that it has obtained the drug registration certificate for dapagliflozin tablets (10mg and 5mg), indicated for type 2 diabetes and heart failure.
NewTimeSpace News: On 21 August 2026, LEADS BIOLABS-B (09887.HK) announced that the NDA for Virexin, its self-developed PD-L1/4-1BB bispecific antibody, as monotherapy for advanced pretreated EP-NEC has been accepted by the NMPA, making it the world's first such antibody submitted for approval.
NewTimeSpace News: On August 21, 2026, BIDU-SW (09888.HK) edged higher in the afternoon session. As of 14:14, the stock was quoted at HK$93.10, up 1.03%.
NewTimeSpace (newtimespace.com) News, On August 21, 2026, the chip theme rebounded, while ASMPT (00522.HK) traded weaker amid fluctuations. As of 13:31, the company quoted HKD 158.500, down 1.43%.
NewTimeSpace (newtimespace.com) News, On August 21, 2026, the robot theme moved with volatility, while XIAOMI-W (01810.HK) strengthened. As of 13:15, the company quoted HKD 28.840, up 3.89%.
NewTimeSpace News: On 20 August 2026, LUYE PHARMA (02186.HK) voluntarily announced that its therapeutic mRNA vaccine LY01620 is about to initiate a Phase II clinical trial in China for patients with HPV16-positive HSIL; the Phase I study showed an HPV viral clearance rate of nearly 90% and histological improvement approaching standard surgical levels, with the treatment being non-invasive and not affecting fertility.
NewTimeSpace News: On 21 August 2026, CSTONE PHARMA-B (02616.HK) voluntarily announced that the IND of CS5007, an EGFR/HER3 bispecific ADC, has been fast-tracked and approved by the NMPA in 23 working days; its global multi-center Phase I trial was initiated in Australia in June 2026 with the first patient enrolled, and approximately 310 patients are expected to be enrolled.
